Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations of C1 esterase inhibitor

Pharmaceutical formulations of C1 esterase inhibitor

US Patent 11554156 · Granted Jan 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Truncated von Willebrand Factor polypeptides for treating hemophilia2023
Method for improving the stability of purified Factor VIII after reconstitution2022
Protein purification and virus inactivation with alkyl glycosides2022
Method for improving the stability of purified Factor VIII after reconstitution2021
Truncated von Willebrand factor polypeptides for treating hemophilia2020
Method for improving the stability of purified factor VIII after reconstitution2020
Factor VIII formulation2019
Method for improving the stability of purified factor VIII after reconstitution2018
Covalent complex of von Willebrand Factor and factor VIII, compositions, and use2018
Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving t2016
Use of sulfated glycosaminoglycans for improving the bioavailability of factor V2016
Method for improving the stability of purified factor VIII after reconstitution2016